Skip to main content

Table 2 Blood Pressure and metabolism in hypertensive patients with no cognitive impairment and cognitive function decline

From: Physical activity, sleep disorders, and type of work in the prevention of cognitive function decline in patients with hypertension

Variables

NCI(n = 602)

CFD(n = 131)

P-value

 Duration of hypertension(m)

111.00[58.75, 179.00]

134.00[67.00, 219.00]

0.020*

 SBP, mmHg

140.51 ± 11.79

144.59 ± 13.52

0.001*

 DBP, mmHg

82.54 ± 10.17

84.62 ± 9.62

0.033*

 LAP index

27.49[11.38, 48.59]

31.80[17.36, 53.13]

0.026*

Laboratory testing parameters

 FBG, mmol/L

5.76[5.20, 7.07]

5.94[5.26, 7.24]

0.255

 TG, mmol/L

1.32[0.95, 1.94]

1.36[0.93, 1.77]

0.911

 TC, mmol/L

4.58[3.76, 5.43]

4.45[3.42, 5.36]

0.216

 LDL-C, mmol/L

2.67[2.03, 3.37]

2.54[1.88, 3.17]

0.131

 SCr, μmoI/L

65.00[54.68, 78.00]

71.00[59.50, 87.00]

0.001*

  1. Abbreviations: NCI no cognitive impairment, CFD cognitive function decline, SBP systolic blood pressure, DBP diastolic blood pressure, LAP lipid accumulation product, FBG fasting blood glucose, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, SCr serum creatinine
  2. *Statistically significant value (p < 0.05)